Literature DB >> 21491205

Bacteriophages as twenty-first century antibacterial tools for food and medicine.

Damien Maura1, Laurent Debarbieux.   

Abstract

Antibiotic-resistant bacteria are an increasing source of concern in all environments in which these drugs have been used. More stringent regulations have led to a slow but sure decrease in antibiotic use in the food industry worldwide, but have also stimulated the search for alternative antibacterial agents. In medicine, the number of people infected with pan-resistant bacteria is driving research to develop new treatments. Within these contexts, studies on the use of bacteriophages in both medicine and the food industry have recently flourished. This renewed interest has coincided with the demonstration that these viruses are involved in geochemical cycles, revolutionizing our vision of their ecological role on our planet. Bacteriophages have co-evolved with bacteria for billions of years and retain the ability to infect bacteria efficiently. They are undoubtedly one of the best potential sources of new solutions for the management of undesirable bacteria.

Entities:  

Mesh:

Year:  2011        PMID: 21491205     DOI: 10.1007/s00253-011-3227-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  26 in total

1.  Assessing the conformational changes of pb5, the receptor-binding protein of phage T5, upon binding to its Escherichia coli receptor FhuA.

Authors:  Cécile Breyton; Ali Flayhan; Frank Gabel; Mathilde Lethier; Grégory Durand; Pascale Boulanger; Mohamed Chami; Christine Ebel
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

2.  Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.

Authors:  Victor Krylov; Olga Shaburova; Elena Pleteneva; Sergey Krylov; Alla Kaplan; Maria Burkaltseva; Olga Polygach; Elena Chesnokova
Journal:  Virol Sin       Date:  2015-02-05       Impact factor: 4.327

3.  Characterization and Genome Sequence of Marine Alteromonas gracilis Phage PB15 Isolated from the Yellow Sea, China.

Authors:  Yu Gao; Qian Liu; Min Wang; Guihua Zhao; Yong Jiang; Gill Malin; Zheng Gong; Xue Meng; Zhaoyang Liu; Tongtong Lin; Yutong Li; Hongbing Shao
Journal:  Curr Microbiol       Date:  2017-04-20       Impact factor: 2.188

Review 4.  Bacteriophage biocontrol of foodborne pathogens.

Authors:  Mustafa Kazi; Uday S Annapure
Journal:  J Food Sci Technol       Date:  2015-10-26       Impact factor: 2.701

5.  Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium.

Authors:  Bruce S Seal
Journal:  Poult Sci       Date:  2013-02       Impact factor: 3.352

Review 6.  Kiwifruit bacterial canker: an integrative view focused on biocontrol strategies.

Authors:  Carla Pereira; Pedro Costa; Larindja Pinheiro; Victor M Balcão; Adelaide Almeida
Journal:  Planta       Date:  2021-01-27       Impact factor: 4.116

7.  The role of regulated clinical trials in the development of bacteriophage therapeutics.

Authors:  Helena Mrt Parracho; Ben H Burrowes; Mark C Enright; Malcolm L McConville; David R Harper
Journal:  J Mol Genet Med       Date:  2012-04-23

8.  Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Yan D Niu; Kim Stanford; Andrew M Kropinski; Hans-Wolfgang Ackermann; Roger P Johnson; Yi-Min She; Rafiq Ahmed; Andre Villegas; Tim A McAllister
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

9.  A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.

Authors:  Steven M Swift; Bruce S Seal; Johnna K Garrish; Brian B Oakley; Kelli Hiett; Hung-Yueh Yeh; Rebekah Woolsey; Kathleen M Schegg; John Eric Line; David M Donovan
Journal:  Viruses       Date:  2015-06-12       Impact factor: 5.048

Review 10.  A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.

Authors:  Victor Krylov; Olga Shaburova; Sergey Krylov; Elena Pleteneva
Journal:  Viruses       Date:  2012-12-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.